New York Genome Center Inc
81% goes to programs $2 to raise $100 Strong reserves
New York Genome Center Inc is a 501(c)(3) organization based in New York, New York, registered in 2012, with $82,342,631 in FY2024 revenue. CharityIndex grades it A, and it directs about 81% of spending to programs.
101 Avenue of Americas 7th Floor, New York, NY, 10013 EIN 80-0631734 Since 2012
Revenue (FY2024)
$82.3M
▼ 11.4% vs prior year
Health median: $840K
Expenses (FY2024)
$84.3M
Net assets
$43.9M
Employees
284
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
A
AProgram efficiency40% of the rating81% to programs · $2 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For New York Genome Center Inc: 81% to programs · $2 to raise $100 earns a A on this criterion. See the exact thresholds →
B+Financial health25% of the rating6 mo reserves · -2% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For New York Genome Center Inc: 6 mo reserves · -2% margin earns a B+ on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For New York Genome Center Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
A+Transparency10% of the rating5 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For New York Genome Center Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
Providing global leadership in human genome research and its translation into clinical care.
What they do
Clinical sequencing: nygc's clep/clia certified clinical laboratory is authorized by the new york state department of health to offer the following approved clinical tests: constitutional whole genome sequencing for undiagnosed disease, constitutional whole genome sequencing for predispositional genetic screening, oncology whole genome and transcriptome sequencing, targeted variant testing using sanger sequencing, maternal cell contamination testing, and aneuploidy screening.
Contact & location
- Address
- 101 Avenue of Americas 7th Floor, New York, NY, 10013
- City
- New York
- State
- New York
- Category
- Health Care
- Subcategory
- Hospitals
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $18.8M (FY2013) to $82.3M (FY2024) across 12 reported years.
Financial snapshot
Financial health & position (FY2024)
Liabilities $123.0MNet assets $43.9M
Operating margin
-2.4%
Spent more than it raised in the latest fiscal year.
Total assets
$167.0M
Total liabilities
$123.0M
Net assets
$43.9M
Salaries & benefits
$38.0M
45% of expenses
Board members
24
23 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $82,342,631▼11.4% | $84,343,480▲3.0% | $43,916,540▼4.4% | $166,954,755▼9.3% | 990 |
| 2023 | $92,940,429▲36.9% | $81,872,824▲13.4% | $45,916,074▲31.8% | $184,052,230▲1.3% | 990 |
| 2022 | $67,901,686▼6.1% | $72,195,873▲4.5% | $34,848,469▼11.0% | $181,740,451▲113% | 990 |
| 2021 | $72,299,111▲18.9% | $69,108,421▼4.4% | $39,142,656▲8.9% | $85,222,125▲2.0% | 990 |
| 2020 | $60,783,989▲43.9% | $72,306,280▼9.8% | $35,951,966▼24.3% | $83,547,232▼14.0% | 990 |
| 2019 | $42,244,445▼67.1% | $80,199,768▼5.2% | $47,474,257▼44.4% | $97,126,046▼34.7% | 990 |
| 2018 | $128,448,950▲35.7% | $84,558,185▼8.4% | $85,429,580▲106% | $148,772,470▲30.3% | 990 |
| 2017 | $94,623,532▼28.4% | $92,285,875▼6.0% | $41,538,815▲6.0% | $114,196,275▼6.5% | 990 |
| 2016 | $132,077,537▲65.5% | $98,213,444▲28.7% | $39,201,158▲635% | $122,070,905▲10.8% | 990 |
| 2015 | $79,803,098▲33.1% | $76,300,231▲32.2% | $5,337,065▲191% | $110,178,881▼3.6% | 990 |
| 2014 | $59,936,565▲218% | $57,735,760▲60.7% | $1,834,198▲855% | $114,312,997▲10.0% | 990 |
| 2013 | $18,845,314 | $35,937,893▲84.2% | $192,130▼98.9% | $103,919,877▲55.1% | 990 |
| 2012 | — | $19,511,091▲576% | $17,284,709▲4.5% | $66,993,120▲49.7% | 990 |
| 2011 | — | $2,886,818 | $16,538,408 | $44,766,025 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2024)
Highest-paid: Tom Maniatis Phd — $675,040 (0.80% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Tom Maniatis Phd | Scientific Director & Ceo | 40 | $675,040 |
| Sarah Lesser Avins | Svp, Advancement & Chief D | 40 | $566,991 |
| Elizabeth Brooks O'brien | Vp & General Counsel | 40 | $468,516 |
| Soren Germer | Svp, Genome Technologies | 40 | $439,717 |
| Carol Ashe | Chief Business Officer | 40 | $438,815 |
| Maria Joanta | Chief Financial Officer | 40 | $385,785 |
| Thomas Lehner | Sci Dir, Neuro Dg (through 11/24) | 40 | $372,482 |
| Michael Charles Zody | Scientific Dir, Comp Biolo | 40 | $371,713 |
| Shailaja Gargeya | Senior Dir, Software Engin | 40 | $349,593 |
| Charles Gagnon | Chief Information Officer | 40 | $341,546 |
| Dayna M Oschwald | Chief of Staff | 40 | $294,329 |
| Christopher Phifer Black | Sr. Dir., Research Comp. | 40 | $263,806 |
| Avinash Vijay Abhyankar | Director, Clinical Bioinform. | 40 | $259,321 |
| Catherine E Reeves | Sr. Dir., Sequencing Operations | 40 | $241,489 |
| Alondra Nelson Phd | Director (started 6/24) | 1 | — |
| Anthony B Evnin Phd | Director | 1 | — |
| Barbara Rosati Phd | Director (started 10/24) | 1 | — |
| Bruce Stillman Phd | Director | 1 | — |
| Dafna Bar-sagi Phd | Director | 1 | — |
| David N Spergel Phd | Director (started 3/24) | 1 | — |
Top vendors & contractors (FY2024)
| Contractor | Services | Paid |
|---|---|---|
| Donnelly Mechanical | Engineering Services | $783,173 |
| Guardian Services Industries Inc | Cleaning Services | $399,966 |
| Howson & Howson LLP | Legal Services | $360,656 |
| Spencerstuart | Recruiting Services | $224,340 |
| Rsm Us LLP | Consulting Services | $192,350 |
Grants received · $50.9M total
78 grants to New York Genome Center Inc totaling $50.9M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Jewish Communal Fund | In furtherance of grantee's tax-exempt purpose | 2024 | $2,100,000 |
| Cold Spring Harbor Laboratory | Research | 2024 | $237,165 |
| American Cancer Society Inc | Extramural research | 2024 | $217,500 |
| American Heart Association Inc | Research | 2024 | $156,640 |
| Silicon Valley Community Foundation | Health | 2024 | $100,000 |
| Amyotrophic Lateral Sclerosis Assn | Post doctoral fellowship | 2024 | $75,000 |
| The Milken Institute | Bipolar disorder research | 2023 | $4,411,628 |
| Jewish Communal Fund | In furtherance of grantee's tax-exempt purpose | 2023 | $2,100,000 |
| National Philanthropic Tr | Religion | 2023 | $1,506,000 |
| Trustees of Columbia University | Research | 2023 | $1,377,676 |
| Cornell University | Research | 2023 | $1,133,497 |
| Cold Spring Harbor Laboratory | Research | 2023 | $592,395 |
| University of Pittsburgh | Research- subcontract | 2023 | $209,726 |
| Broad Institute Inc | Research | 2023 | $104,093 |
| The New York Community Trust | For program support. | 2023 | $25,000 |
Grants made · $2.1M in FY2024
14 grants totaling $2.1M in FY2024. All grants made by New York Genome Center Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| Trustees of Columbia University | Research subaward | $375,710 |
| Johns Hopkins University | Research subaward | $354,063 |
| Memorial Sloan-kettering Cancer Center | Research subaward | $279,421 |
| Nyu Grossman School of Medicine | Research subaward | $205,910 |
| Cold Spring Harbor Laboratory | Research subaward | $200,000 |
| Icahn School of Medicine At Mount Sinai | Research subaward | $143,729 |
| Cornell University | Research subaward | $111,815 |
| Morehouse School of Medicine Inc | Research subaward | $95,176 |
| Rockefeller University | Research subaward | $93,797 |
| The Feinstein Institute For Medical Research | Research subaward | $79,582 |
| Rutgers the State University | Research subaward | $65,864 |
| New York University | Research subaward | $38,422 |
| Regents of the University of California | Research subaward | $37,951 |
| Yale University | Research subaward | $20,951 |
Similar organizations in Health
Health
Memorial Hospital of William F and Gertrude F Jones Inc
Wellsville, NY
$82.7M
Aannual revenue
- Health
Royal Charter Properties - East Inc
New York, NY
$83.1M
C+annual revenue
Health
Menorah Home & Hospital For the Aged & Infirm
New York, NY
$81.5M
Aannual revenue
Health
Genesee Region Home Care Association Inc
Rochester, NY
$84.2M
Aannual revenue
- Health
Hss Properties Corporation
New York, NY
$79.7M
A+annual revenue
- Health
Montefiore Medicine Academic Health Self Insurance Trist
Bronx, NY
$85.3M
Cannual revenue
Health
Brooklyn Ambulatory Care PC
Westbury, NY
$79.3M
C+annual revenue
Health
Amsterdam Nursing Home Corporation
New York, NY
$85.5M
Aannual revenue
Carnegie Cardiovascular PC
Westbury, NY
$79.1M
Bannual revenue
Health
Elizabethtown Community Hospital
Elizabethtown, NY
$86.0M
Aannual revenue
Compare New York Genome Center Inc
Frequently asked questions
- Is New York Genome Center Inc a legitimate nonprofit?
- Yes. New York Genome Center Inc is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 80-0631734, based in New York, New York. Donations are tax-deductible.
- What is New York Genome Center Inc's EIN?
- New York Genome Center Inc's Employer Identification Number (EIN) is 80-0631734.
- How much revenue does New York Genome Center Inc report?
- New York Genome Center Inc reported $82,342,631 in total revenue on its fiscal year 2024 IRS Form 990 filing.
- How much of New York Genome Center Inc's spending goes to programs?
- New York Genome Center Inc spends about 81% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does New York Genome Center Inc have?
- CharityIndex grades New York Genome Center Inc A, based on program efficiency and fundraising cost.
- How much does New York Genome Center Inc's highest-paid employee make?
- The highest reported compensation on New York Genome Center Inc's latest Form 990 is $675,040, paid to Tom Maniatis Phd (Scientific Director & Ceo).
More nonprofits in New York
Explore more
Data for New York Genome Center Inc (EIN 80-0631734) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.